Goals & Objectives

Develop

…a comprehensive electronic repository of training materials and educational resources to support evidence-based treatment of opioid use disorder.

Create

…a mentoring program to provide guidance, direction and advice to help prescribers and key health professionals who are new to the field of Medication Assisted Treatment.

Continue

…to offer waiver training for physicians interested in providing buprenorphine treatment under the DATA 2000.

Develop a comprehensive electronic repository of training materials and educational resources to support evidence-based treatment of opioid use disorder.

Training is designed to increase the knowledge base and clinical proficiency of prescribers and providers from diverse multi-disciplinary healthcare backgrounds. An on-line curriculum includes training materials expanded from Providers’ Clinical Support System for Opioid Therapies (PCSS-O) and Physicians’ Clinical Support System for Buprenorphine (PCSS-B) to include significant additional content such as:

  1. Patient selection and matching with treatment setting (residential, outpatient program,  office-based) and specific medications (methadone, buprenorphine, or naltrexone);
  2. practical guidelines for detoxification (both outpatient and inpatient);
  3. implementing antagonist-based treatment, managing long-term maintenance on medications;
  4. transitioning from agonist- to antagonist-based treatment;
  5. managing substance use and co-occurring psychiatric disorders;
  6. treatment of individuals with co-occurring medical problems and chronic pain;
  7. treatment in specialized populations such as adolescents, elderly, pregnant women, and those involved in veterans and criminal justice healthcare systems (for detailed description of the training curriculum, see below).

The content of educational resources is overseen by a panel of experienced clinicians, researchers, and educators forming a Clinical Expert Panel.

Create a mentoring program to provide guidance, direction and advice to help prescribers and key health professionals who are new to the field of Medication Assisted Treatment.

Our approach to developing a mentor system for this project is to use the successful elements of the training programs implemented with Physicians’ Clinical Support System for Buprenorphine (PCSS-B) and Providers’ Clinical Support System for Opioid Therapies (PCSS-O). It expands upon existing methods by adopting a comprehensive approach to the mentoring program.

The program selects and trains mentors, subsequently mentors are matched with mentees and are monitored and supported by the Mentoring Panel. Communications between individual mentors and mentees is primarily via phone and Internet (email, video). A listserv allows mentees and mentors to post questions and to encourage communication among a wide range of providers.

A “Mentor-on-Call” is available, on a rotating basis, to answer questions and to review and respond to postings on the listserv.

Continue to offer waiver training for physicians interested in providing buprenorphine treatment under the DATA 2000.

The web-based training includes eight hours of modules focused on buprenorphine that, once completed, qualify for the waiver to prescribe. Training continues using the Half-and-Half format (3.75 hours of on-your-own training and 4.25 hours of face-to-face training with an instructor). AAAP focuses on training resident physicians with an emphasis on primary care and psychiatry, AOAAM will emphasize training of rural practicing physicians and ASAM will train primary care and OB-GYN residents. The course content used in existing Physicians’ Clinical Support System for Buprenorphine (PCSS-B) trainings have been revised to include information about other pharmacological strategies (naltrexone and methadone), including matching patients to treatment, as well as recommendations for practice informed by recent research and clinical experience.